Preventive agent or therapeutic agent for disease caused by abnormal bone metabolism

Details for Australian Patent Application No. 2008283297 (hide)

Owner Teijin Pharma Limited

Inventors Azuma, Yoshiaki; Nishiga, Miyuki; Takagi, Kenichiro; Ochiai, Eiji

Agent Davies Collison Cave

Pub. Number AU-A-2008283297

PCT Pub. Number WO2009/017222

Priority 60/935,262 02.08.07 US

Filing date 1 August 2008

Wipo publication date 5 February 2009

International Classifications

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 33/42 (2006.01) Medicinal preparations containing inorganic active ingredients - Phosphorus

A61P 19/08 (2006.01) Drugs for skeletal disorders

Event Publications

18 February 2010 PCT application entered the National Phase

  PCT publication WO2009/017222 Priority application(s): WO2009/017222

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008283301-Cell screening method

2008283289-Work conveying apparatus